Arya Bolurfrushan, the former Goldman Sachs banker who established AppliedAI in Abu Dhabi, has admitted his role in an elaborate insider trading operation that exploited confidential merger information obtained by attorneys at prestigious American law firms. Unsealed court records from Monday reveal that Bolurfrushan entered a guilty plea in June 2025 to conspiring to commit securities fraud, marking a significant development in a sprawling federal investigation centred in Boston that has ensnared dozens of participants across the financial and legal sectors.
The case underscores a persistent vulnerability in capital markets: the asymmetry of information available to legal professionals handling sensitive transactions. Attorneys advising on mergers possess knowledge of impending deals long before public announcement, and the Bolurfrushan case demonstrates how this advantage can be monetised through networks connecting lawyers, traders, and dealmakers. The scheme operated over an extended period, exploiting multiple high-value transactions and generating substantial illicit profits before federal authorities intervened.
Bolurfrushan's cooperation with prosecutors signals the fragmentation occurring within the alleged conspiracy. According to the agreement, prosecutors recommended sentencing him to two years imprisonment and requiring him to forfeit US$954,496 derived from his trading activities. Nine other participants similarly entered guilty pleas through secret proceedings before the indictments became public, suggesting that federal investigators have constructed a persuasive case built upon testimony and evidence from insiders willing to testify against their co-conspirators.
Central to the scheme was Nicolo Nourafchan, a lawyer who worked sequentially at Sidley Austin, Latham & Watkins, and Goodwin Procter, and Robert Yadgarov, a personal injury attorney. Prosecutors allege that Nourafchan and Yadgarov recruited Bolurfrushan into the conspiracy in 2023 after meeting him through a family connection. In exchange for advance notice of pending mergers, Bolurfrushan allegedly provided a percentage of trading profits to the two lawyers, creating a financial incentive structure that bound the parties together through mutual interest in concealment.
The most documented transaction involved Orchard Therapeutics' planned acquisition by Kyowa Kirin Co Ltd. In September 2023, while employed at Goodwin Procter, Nourafchan accessed electronic documents related to the transaction despite having no official role in the matter. He immediately notified Bolurfrushan, enabling the trader to accumulate Orchard securities ahead of the public announcement. When the deal became known, Bolurfrushan realised approximately US$950,000 in trading profits, subsequently distributing roughly US$60,000 to Nourafchan and Yadgarov. This transaction exemplifies the straightforward mechanics of the scheme: privileged information flowing from lawyer to trader, resulting in concentrated wealth capture.
The conspiracy extended into 2024, as evidenced by Bolurfrushan's involvement in trading based upon early knowledge of investment firm Sixth Street's planned acquisition of insurer Enstar for US$5.1 billion. This second significant transaction demonstrates that neither Bolurfrushan nor his co-conspirators retreated from the scheme after the initial profitable venture, suggesting either confidence in their operational security or an inability to resist the financial rewards the arrangement provided. The continued activity also indicates that detecting insider trading schemes remains challenging despite considerable regulatory focus and technological advancement in surveillance capabilities.
Nourafchan and Yadgarov have maintained their not guilty pleas and await trial, presenting a stark contrast to Bolurfrushan's admission. Their decision to contest the charges may reflect confidence in legal defence strategies or may indicate their attorneys' assessment that fighting the evidence serves their clients' interests better than early cooperation. The trial will likely illuminate additional operational details of the conspiracy and potentially reveal communications or transactions not yet publicly disclosed.
For Malaysian investors and financial professionals, this case carries particular relevance. The incident reveals systemic weaknesses in professional compliance at international law firms, even those with sophisticated internal governance structures. Goodwin Procter, Sidley Austin, and Latham & Watkins rank among the world's most prominent legal institutions, yet their controls failed to prevent Nourafchan's unauthorised document access or subsequent information transfer. This suggests that aggressive insider trading schemes can flourish even within organisations with substantial compliance infrastructure and reputational stakes.
The Abu Dhabi-based nature of Bolurfrushan's AppliedAI also highlights how global financial networks can facilitate misconduct. Trading profits generated from US securities markets could flow through various jurisdictions and financial intermediaries, complicating detection and enforcement. Southeast Asian regulators and market participants should recognise that sophisticated international schemes often involve layers of geographic separation between information source, trader, and beneficiary, making cross-border cooperation among authorities essential for effective prevention.
The US Securities and Exchange Commission simultaneously resolved civil claims against Bolurfrushan, securing his asset forfeiture and preventing him from serving as a corporate officer or director. This parallel civil action demonstrates the multi-pronged enforcement approach available to American authorities and illustrates how criminal guilty pleas facilitate rapid civil resolution. For Malaysian companies with US listings or trading activity, such cases remind management that insider trading violations can trigger both criminal prosecution and permanent bars from securities-related activities.
The broader investigation encompasses dozens of other individuals facing charges, suggesting investigators have mapped an extensive network rather than merely pursuing isolated bad actors. As additional trials progress and witness testimony emerges, further details about recruitment patterns, profit distribution mechanisms, and information-sharing protocols will likely surface. Malaysian financial professionals should monitor these developments closely, as methodologies and warning signs identified in the US investigation may provide templates for detecting similar schemes within Southeast Asian markets and organisations.
Bolurfrushan's guilty plea also raises questions about the screening processes and compliance cultures at firms involved in the scheme. How did legal professionals justify transferring confidential client information for personal profit? Did they rationalise their actions as low-risk given their technical knowledge of securities law? Understanding the psychological and institutional factors enabling such breaches could help Malaysian firms strengthen prevention mechanisms and foster stronger ethical cultures among lawyers and financial professionals handling material non-public information.
